Skip to content

NuVasive 6904485Recalls & reported problems

Nuvasive, Inc. · Universal Inserter, XLIF Angled · Class 2

Data updated Oct 16, 2026 from official FDA records · Editorial policy

Adverse event reports
3
Deaths reported
0
Injuries reported
1
Recalls naming it
0

Summary

The FDA's MAUDE database contains 3 adverse event reports that list this exact device (DI 00887517389091), received between Sep 18, 2023 and Dec 29, 2025 — classified as 1 injury, 2 malfunctions.

The most frequently reported specific device problem is “Fracture” (2 reports).

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 16, 2026.

Reports received per month

Nov 2023: 0 reportsDec 2023: 0 reportsJan 2024: 0 reportsFeb 2024: 0 reportsMar 2024: 0 reportsApr 2024: 0 reportsMay 2024: 0 reportsJun 2024: 0 reportsJul 2024: 0 reportsAug 2024: 0 reportsSep 2024: 0 reportsOct 2024: 0 reportsNov 2024: 0 reportsDec 2024: 1 reportsJan 2025: 0 reportsFeb 2025: 0 reportsMar 2025: 0 reportsApr 2025: 0 reportsMay 2025: 0 reportsJun 2025: 0 reportsJul 2025: 0 reportsAug 2025: 0 reportsSep 2025: 0 reportsOct 2025: 0 reportsNov 2025: 0 reportsDec 2025: 1 reportsJan 2026: 0 reportsFeb 2026: 0 reportsMar 2026: 0 reportsApr 2026: 0 reportsMay 2026: 0 reportsJun 2026: 0 reportsJul 2026: 0 reportsAug 2026: 0 reportsSep 2026: 0 reportsOct 2026: 0 reports2024202520261
Last 36 months. The most recent month may be incomplete.

Most reported problems

Device problems

  • Fracture2
  • Difficult to Insert1

Patient problems

  • No Clinical Signs, Symptoms or Conditions2
  • Low Blood Pressure/ Hypotension1

Recent adverse event reports

The 3 most recent of 3 reports, in the reporter's own words as published by the FDA.

  • MalfunctionDec 29, 2025Difficult to Insert; Difficult to Insert

    IT WAS REPORTED THAT XLIF TRIAL WITH INSERTER PASSED THROUGH TO THE OPPOSITE SIDE AT INTERVERTEBRAL SPACE OF L4/L5 LEVEL. THE SURGEON STRUCK XLIF INSERTER HARDLY WHILE INSERTING A TRIAL INTO THE INTERVERTEBRAL SPACE AT THE L4/L5 LEVEL SINCE IT WAS NARROW. BLEEDING OCCURRED WHEN THE SURGEON REMOVED THE TRIAL WITH INSERTER, AND THE PATIENT¿S BLOOD PRESSURE DROPPED. AFTER COMPRESSION HAEMOSTASIAS, BLOOD PRESSURE RECOVERED TO NORMAL LIMITS WITHIN APPROXIMATELY ONE MINUTE. AFTER CONFIRMING SUCCESSFUL HAEMOSTASIAS, THE SURGEON INSERTED SPINAL CAGES INTO THE L3~L5 INTERVERTEBRAL SPACE BY XLIF, AND FIXED SPINE BY POSTERIOR SPINAL FIXATION AND CLOSED THE SURGERY. THERE WAS NO FLUCTUATION IN THE MOTOR-EVOKED POTENTIAL (MEP) BLOOD TRANSFUSIONS WERE ALSO NOT ADMINISTERED. NO OTHER ADVERSE PATIENT CONSEQUENCES REPORTED.

    Patient problems: Low Blood Pressure/ Hypotension

    MAUDE report 23917073 ↗
  • MalfunctionDec 4, 2024Fracture; Fracture

    IT WAS REPORTED THAT DURING A PROCEDURE, THE TRIAL INSERTER TIP FRACTURED OFF INSIDE THE TRIAL. THE FRACTURED PORTION WAS RETRIEVED ALONG WITH THE TRIAL AND NO FRAGMENT WAS LEFT IN-SITU. THERE WAS NO REPORTED IMPACT TO THE PATIENT, USER, OR PROCEDURE. NO ADDITIONAL INFORMATION IS AVAILABLE.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 20848720 ↗
  • InjurySep 18, 2023Fracture; Fracture

    N/A.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 17769807 ↗

Other Intervertebral fusion device with bone graft, lumbar devices

All Intervertebral fusion device with bone graft, lumbar devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page